CE认证
皮肤填充剂
Yvoire Y-Solution 540 is a cross-linked hyaluronic acid dermal filler by YVOIRE, developed for aesthetic corrections that call for projection the face can move with. Clinics, aesthetic physicians and dermatologists typically choose it for anti-ageing correction and facial projection support, where a balance of elasticity and cohesion matters more than static filling; the Y-Solution numbers are lift tiers rather than concentrations, and the 540 and the 720 share the same stated composition while differing in lift positioning. The product incorporates 20 mg/mL (2.0%) of cross-linked hyaluronic acid with 0.3% lidocaine, made by the S-HICE process, and is for professional use by qualified practitioners only. It comes as one 1 mL syringe with two Terumo thin-wall 27G needles enclosed; shelf life is 17 months, shorter than the 24 months of the Classic, Volume and Contour references, so check the date when rotating stock.
主要优势： Yvoire Y-Solution 540
- Balances elasticity and cohesion, which the manufacturer describes as giving the gel spring-like characteristics
- Delivers visible projection while adapting to the dynamics of facial expression
- Cross-linked hyaluronic acid at 20 mg/mL, a higher concentration than the 360 reference in the same range
- Built on the manufacturer's S-HICE cross-linking process
- Includes 0.3% lidocaine, intended to improve patient comfort during injection
- Supplied with two Terumo thin-wall 27G needles
- Supports anti-ageing aesthetic correction and facial balancing
- Part of the Y-Solution 360, 540 and 720 range, where the number is a lift tier rather than a concentration
适应症与专业用途
主要适应症
- Anti-ageing aesthetic treatment
- Facial projection support
- Treatments requiring a balance of elasticity and cohesion
专业用途
Yvoire Y-Solution 540 is a sterile, single-use injectable medical device supplied for administration by qualified medical practitioners only. Each syringe is intended for a single patient in a single session; any residual product must be discarded and never retained for reuse. Administration requires an aseptic technique and practitioner competence in facial anatomy and in the management of vascular complications, including intravascular occlusion. The manufacturer gives the application zone as the face and the injection site as the facial skin layer, and encloses two Terumo thin-wall 27G needles. Patients must be screened for sensitivity to amide-type local anaesthetics before treatment because the formulation contains lidocaine.
治疗部位
- Face
适用患者
Suitable for adult patients seeking correction of age-related volume loss or facial projection support, with suitability determined by the treating practitioner following clinical assessment. Selection should account for skin quality, degree of volume deficit and the mobility of the treated region, since this reference is formulated for areas subject to facial expression. Patients with a known hypersensitivity to hyaluronic acid preparations or to amide-type local anaesthetics such as lidocaine should not be treated.
作用原理： Yvoire Y-Solution 540
Yvoire Y-Solution 540, listed by some suppliers simply as Yvoire 540, works through cross-linked hyaluronic acid at 20 mg/mL (2.0%), made by the manufacturer's S-HICE process and formulated so that elasticity and cohesion are balanced rather than traded against each other. The intended behaviour is spring-like: the gel holds projection under load but flexes as the face moves, which is why the Y-Solution range is positioned around projection that survives expression rather than around static volume. At 20 mg/mL this reference is a firmer gel than the 12 mg/mL 360; it shares its stated composition and its 27G needles with the 720, the two differing in lift positioning rather than in concentration. The 0.3% lidocaine acts locally to reduce discomfort during injection and does not contribute to the filling effect.
为什么选择在 Allpara 订购
Allpara 提供正品、经过验证的 YVOIRE 产品，来自经过严格审核的供应商，具备完整的批次可追溯性和专家支持。我们为诊所和医美专业人士提供CE认证产品、从欧盟仓库快速配送至欧盟各地，以及具有竞争力的专业价格。我们关注的是您患者的安全、满意度和效果，并提供专属售后支持，让您安心无忧。
常见问题
Is Yvoire 540 the same product as Yvoire Y-Solution 540?
Yes. Yvoire 540 is a shortened supplier listing of the same reference, and Yvoire Y Solution 540 is the same name written without the hyphen. The official product name is Yvoire Y-Solution 540, and that is the reference supplied by Allpara.
How does Yvoire Y-Solution 540 differ from Yvoire Y-Solution 360 and Yvoire Y-Solution 720?
Yvoire Y-Solution 360 is the lightest at 12 mg/mL with finer 29G needles. Yvoire Y-Solution 540 and Yvoire Y-Solution 720 both state 20 mg/mL with 0.3% lidocaine and two 27G needles, so they differ in lift positioning rather than in stated composition. The Y-Solution numbers are lift tiers, not concentrations.
What is the shelf life of Yvoire Y-Solution 540?
17 months from manufacture, shorter than the 24 months of the other Yvoire references. Check the date on the carton when you order and when you rotate stock.
更多产品： LG Chem
诊所替代选择
美塑疗法
水光针
/ 最近浏览
继续浏览
Yvoire Y-Solution 540 is a cross-linked hyaluronic acid dermal filler by YVOIRE, developed for aesthetic corrections that call for projection the face can move with. Clinics, aesthetic physicians and dermatologists typically choose it for anti-ageing correction and facial projection support, where a balance of elasticity and cohesion matters more than static filling; the Y-Solution numbers are lift tiers rather than concentrations, and the 540 and the 720 share the same stated composition while differing in lift positioning. The product incorporates 20 mg/mL (2.0%) of cross-linked hyaluronic acid with 0.3% lidocaine, made by the S-HICE process, and is for professional use by qualified practitioners only. It comes as one 1 mL syringe with two Terumo thin-wall 27G needles enclosed; shelf life is 17 months, shorter than the 24 months of the Classic, Volume and Contour references, so check the date when rotating stock.
主要优势： Yvoire Y-Solution 540
- Balances elasticity and cohesion, which the manufacturer describes as giving the gel spring-like characteristics
- Delivers visible projection while adapting to the dynamics of facial expression
- Cross-linked hyaluronic acid at 20 mg/mL, a higher concentration than the 360 reference in the same range
- Built on the manufacturer's S-HICE cross-linking process
- Includes 0.3% lidocaine, intended to improve patient comfort during injection
- Supplied with two Terumo thin-wall 27G needles
- Supports anti-ageing aesthetic correction and facial balancing
- Part of the Y-Solution 360, 540 and 720 range, where the number is a lift tier rather than a concentration
适应症与专业用途
主要适应症
- Anti-ageing aesthetic treatment
- Facial projection support
- Treatments requiring a balance of elasticity and cohesion
专业用途
Yvoire Y-Solution 540 is a sterile, single-use injectable medical device supplied for administration by qualified medical practitioners only. Each syringe is intended for a single patient in a single session; any residual product must be discarded and never retained for reuse. Administration requires an aseptic technique and practitioner competence in facial anatomy and in the management of vascular complications, including intravascular occlusion. The manufacturer gives the application zone as the face and the injection site as the facial skin layer, and encloses two Terumo thin-wall 27G needles. Patients must be screened for sensitivity to amide-type local anaesthetics before treatment because the formulation contains lidocaine.
治疗部位
- Face
适用患者
Suitable for adult patients seeking correction of age-related volume loss or facial projection support, with suitability determined by the treating practitioner following clinical assessment. Selection should account for skin quality, degree of volume deficit and the mobility of the treated region, since this reference is formulated for areas subject to facial expression. Patients with a known hypersensitivity to hyaluronic acid preparations or to amide-type local anaesthetics such as lidocaine should not be treated.
作用原理： Yvoire Y-Solution 540
Yvoire Y-Solution 540, listed by some suppliers simply as Yvoire 540, works through cross-linked hyaluronic acid at 20 mg/mL (2.0%), made by the manufacturer's S-HICE process and formulated so that elasticity and cohesion are balanced rather than traded against each other. The intended behaviour is spring-like: the gel holds projection under load but flexes as the face moves, which is why the Y-Solution range is positioned around projection that survives expression rather than around static volume. At 20 mg/mL this reference is a firmer gel than the 12 mg/mL 360; it shares its stated composition and its 27G needles with the 720, the two differing in lift positioning rather than in concentration. The 0.3% lidocaine acts locally to reduce discomfort during injection and does not contribute to the filling effect.
为什么选择在 Allpara 订购
Allpara 提供正品、经过验证的 YVOIRE 产品，具备完整的批次可追溯性、CE认证库存、欧盟范围内快速配送以及专业的售后支持。
常见问题
Is Yvoire 540 the same product as Yvoire Y-Solution 540?
Yes. Yvoire 540 is a shortened supplier listing of the same reference, and Yvoire Y Solution 540 is the same name written without the hyphen. The official product name is Yvoire Y-Solution 540, and that is the reference supplied by Allpara.
How does Yvoire Y-Solution 540 differ from Yvoire Y-Solution 360 and Yvoire Y-Solution 720?
Yvoire Y-Solution 360 is the lightest at 12 mg/mL with finer 29G needles. Yvoire Y-Solution 540 and Yvoire Y-Solution 720 both state 20 mg/mL with 0.3% lidocaine and two 27G needles, so they differ in lift positioning rather than in stated composition. The Y-Solution numbers are lift tiers, not concentrations.
What is the shelf life of Yvoire Y-Solution 540?
17 months from manufacture, shorter than the 24 months of the other Yvoire references. Check the date on the carton when you order and when you rotate stock.
更多产品： LG Chem
查看制造商 →* 专业用途产品。包装可能因批次或市场而异。完整的使用说明和禁忌症请参阅随附的使用说明书。